https://www.selleckchem.com/pr....oducts/cct245737.htm
However, current evidence concerning the dose of caspofungin and fluconazole are limited, and it is not clear whether the routine dose should be adjusted during ECMO support. To investigate the pathogenic gene in a child with optic atrophy and analyze the influence of this gene mutation on protein structure. We collected the clinical record of the 13-year-old girl and her relatives. The child received examinations of the visual acuity, visual field, fundus, OCT, visual-evoked potential (VEP) and the nerve system, underwent brain MRI a
Like
Comment
Share
